NS063965/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2009	2
2010	1
2011	8
2012	9
2013	9
2014	8
2015	11
2016	6
2017	6
2018	5
2019	4
2024	0

1

NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S, Filosa J, Fagan SC, Ergul A. Ward R, et al. Pharmacol Res. 2019 Apr;142:237-250. doi: 10.1016/j.phrs.2019.01.035. Epub 2019 Feb 25. Pharmacol Res. 2019. PMID: 30818045 Free PMC article.

2

Minocycline repurposing in critical illness: focus on stroke.

Liao TV, Forehand CC, Hess DC, Fagan SC. Liao TV, et al. Curr Top Med Chem. 2013;13(18):2283-90. doi: 10.2174/15680266113136660160. Curr Top Med Chem. 2013. PMID: 24059465 Review.

3

Cerebrovascular complications of diabetes: focus on stroke.

Ergul A, Kelly-Cobbs A, Abdalla M, Fagan SC. Ergul A, et al. Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):148-58. doi: 10.2174/187153012800493477. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 22236022 Free PMC article. Review.

4

Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.

Hafez S, Coucha M, Bruno A, Fagan SC, Ergul A. Hafez S, et al. Transl Stroke Res. 2014 Aug;5(4):442-453. doi: 10.1007/s12975-014-0336-z. Epub 2014 Mar 13. Transl Stroke Res. 2014. PMID: 24619488 Free PMC article. Review.

5

Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.

Ergul A, Abdelsaid M, Fouda AY, Fagan SC. Ergul A, et al. J Cereb Blood Flow Metab. 2014 Apr;34(4):553-63. doi: 10.1038/jcbfm.2014.18. Epub 2014 Feb 5. J Cereb Blood Flow Metab. 2014. PMID: 24496174 Free PMC article. Review.

6

Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.

Fouda AY, Artham S, El-Remessy AB, Fagan SC. Fouda AY, et al. Clin Sci (Lond). 2016 Feb;130(4):221-38. doi: 10.1042/CS20150350. Clin Sci (Lond). 2016. PMID: 26769658 Review.

7

Minocycline for short-term neuroprotection.

Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. Elewa HF, et al. Pharmacotherapy. 2006 Apr;26(4):515-21. doi: 10.1592/phco.26.4.515. Pharmacotherapy. 2006. PMID: 16553511 Free PMC article. Review.

8

Treatment of fever after stroke: conflicting evidence.

Wrotek SE, Kozak WE, Hess DC, Fagan SC. Wrotek SE, et al. Pharmacotherapy. 2011 Nov;31(11):1085-91. doi: 10.1592/phco.31.11.1085. Pharmacotherapy. 2011. PMID: 22026396 Free PMC article. Review.

9

Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Ergul A, Hafez S, Fouda A, Fagan SC. Ergul A, et al. Transl Stroke Res. 2016 Aug;7(4):248-60. doi: 10.1007/s12975-016-0464-8. Epub 2016 Mar 30. Transl Stroke Res. 2016. PMID: 27026092 Free PMC article. Review.

10

Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.

Soliman S, Ishrat T, Fouda AY, Patel A, Pillai B, Fagan SC. Soliman S, et al. Transl Stroke Res. 2015 Aug;6(4):309-22. doi: 10.1007/s12975-015-0408-8. Epub 2015 May 26. Transl Stroke Res. 2015. PMID: 26004281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year